In general, cholinesterase inhibitors have shown some benefit for patients with vascular dementia, those with mixed Alzheimer's and vascular dementia, patients with the disease known as "dementia with Lewy bodies, " and dementia from Parkinson's disease.
Haloperidol (Haldol) is indicated in the treatment of behavior issues in a patient with Alzheimer's disease, but can be harmful to a patient with dementia caused by Parkinson's disease.
She said that it guarantees "free personal care for around 280, 000 people suffering from conditions such as serious dementia and Parkinson's disease".